药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pipecuronium
Pibrentasvir
The serum concentration of Pibrentasvir can be increased when it is combined with Eliglustat.
Pipecuronium
Valspodar
The serum concentration of Valspodar can be increased when it is combined with Eliglustat.
Pipecuronium
Pitolisant
The serum concentration of Eliglustat can be decreased when it is combined with Pitolisant.
Pipecuronium
Delamanid
Eliglustat may increase the QTc-prolonging activities of Delamanid.
Pipecuronium
Apalutamide
The serum concentration of Eliglustat can be decreased when it is combined with Apalutamide.
Pipecuronium
Terodiline
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Terodiline.
Pipecuronium
Macimorelin
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Macimorelin.
Pipecuronium
Ivabradine
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Ivabradine.
Pipecuronium
Artemether
The risk or severity of QTc prolongation can be increased when Artemether is combined with Eliglustat.
Pipecuronium
Asenapine
The risk or severity of QTc prolongation can be increased when Asenapine is combined with Eliglustat.
Pipecuronium
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Deutetrabenazine.
Pipecuronium
Iloperidone
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Iloperidone.
Pipecuronium
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Eliglustat.
Pipecuronium
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Eliglustat.
Pipecuronium
Glasdegib
The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Eliglustat.
Pipecuronium
Temafloxacin
The risk or severity of QTc prolongation can be increased when Temafloxacin is combined with Eliglustat.
Pipecuronium
Lithium cation
The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Eliglustat.
Pipecuronium
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Eliglustat.
Pipecuronium
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Eliglustat.
Pipecuronium
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Eliglustat.